Federal health officials say that the manufacturer of a medical instrument at the center of a recent “superbug” outbreak in Los Angeles did not receive federal clearance to sell the device.
The Food and Drug Administration has confirmed that Olympus Corp. did not seek FDA clearance for the latest version of its specialized endoscope, which it began selling in 2010. FDA clearance is required for all substantive updates to medical device sold in the U.S.
Despite the lack of clearance, the FDA said doctors should continue using the device because it’s not clear that a federal review would have prevented the recent infections.
Olympus has now submitted an application for the device that is currently under FDA review
Was this article valuable?
Here are more articles you may enjoy.
AM Best: Social Inflation Drives Surge in Commercial Auto Liability Claims 
Chubb Q3 Net Income Down Slightly on More Catastrophe Losses 
Reuters: DXC in Advanced Talks to Sell Insurance Software Unit for $2.4 Billion 
Report: Auto Insurance Total Loss Frequency Climbs, More Drivers Pay Repairs 
